Meet an Unreasonable Venture
Algal Bio
Cultivating Algae’s Potential, for a Better Future.
Algal Bio is a biotechnology company developing sustainable microalgae-based solutions. Built on over 20 years of research, its platform identifies, screens, and optimizes algae strains for use in nutraceuticals, cosmetics, bioplastics, and carbon capture. Headquartered in Japan with operations in four countries, the company is advancing 35 projects and forging strategic partnerships to scale algae innovations that address environmental, food, and health challenges globally.
Notable Achievements
- Commercialized two products and launched 30+ pipeline projects in 2024.
- Received a CES Innovation Award for its sleep health product.
- Expanding operations across Singapore, Taiwan, Thailand, and other ASEAN countries.
Currently Operating in Six Regions
Press Mentions
May 15, 2025
Unreasonable Impact announces new roster of ventures for the 2025 Asia Pacific programme
Algal Bio has made significant strides in sustainable biotechnology, focusing on algae-based solutions for environmental challenges. Their innovative approaches promise to enhance carbon capture...
Read on WebWire »More Ventures in Food & Water
Get the Unreasonable Newsletter
Get monthly updates on Algal Bio and all of the other ventures working to solve the world's toughest problems.